Hendrik P N Scholl Selected Research

Telangiectasis (Telangiectasia)

5/2013	Macular telangiectasia type 2.
5/2011	Monthly ranibizumab for nonproliferative macular telangiectasia type 2: a 12-month prospective study.
12/2010	Analysis of glutathione S-transferase Pi isoform (GSTP1) single-nucleotide polymorphisms and macular telangiectasia type 2.
12/2010	Clinical evaluation of simultaneous confocal scanning laser ophthalmoscopy imaging combined with high-resolution, spectral-domain optical coherence tomography.
11/2010	Outer retinal hyperreflective spots on spectral-domain optical coherence tomography in macular telangiectasia type 2.
12/2009	Familial asymptomatic macular telangiectasia type 2.
6/2009	Quantification of reduced macular pigment optical density in the central retina in macular telangiectasia type 2.
6/2008	Abnormal macular pigment distribution in type 2 idiopathic macular telangiectasia.
1/2008	Correlation of macular function with retinal thickness in nonproliferative type 2 idiopathic macular telangiectasia.
9/2007	Findings in fluorescein angiography and optical coherence tomography after intravitreal bevacizumab in type 2 idiopathic macular telangiectasia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hendrik P N Scholl Research Topics

Disease

20	Macular Degeneration (Age-Related Maculopathy) 01/2022 - 02/2004
12	Telangiectasis (Telangiectasia) 05/2013 - 01/2007
9	Retinitis Pigmentosa (Pigmentary Retinopathy) 08/2022 - 04/2007
9	Stargardt Disease 01/2022 - 07/2007
7	Atrophy 06/2022 - 11/2005
5	Photophobia (Light Sensitivity) 01/2020 - 08/2007
4	Retinal Detachment (Retinal Detachments) 06/2021 - 01/2019
4	Diabetic Retinopathy (Retinopathy, Diabetic) 04/2020 - 09/2007
4	Retinal Diseases 07/2018 - 12/2003
4	Blindness (Hysterical Blindness) 01/2017 - 07/2008
3	Geographic Atrophy 01/2022 - 08/2009
3	Disease Progression 09/2021 - 10/2009
3	Vision Disorders (Hemeralopia) 06/2021 - 01/2019
3	Inflammation (Inflammations) 01/2021 - 10/2011
3	Pseudoxanthoma Elasticum (Gronblad Strandberg Syndrome) 10/2011 - 12/2009
2	Dry Eye Syndromes (Dry Eye Syndrome) 01/2021 - 01/2019
2	Retinal Degeneration 01/2021 - 12/2016
2	Epiretinal Membrane (Epiretinal Membranes) 06/2019 - 01/2019
2	Vitelliform Macular Dystrophy 10/2010 - 04/2002
2	Deafness (Deaf Mutism) 04/2007 - 07/2004
1	Ganglion Cysts (Ganglion) 01/2022
1	1 Posterior Polymorphous Corneal Dystrophy 01/2022
1	North Carolina type 1 retinal Macular dystrophy 01/2022
1	Leber Hereditary Optic Atrophy (Leber's Hereditary Optic Neuropathy) 01/2022
1	Low Tension Glaucoma 01/2021
1	Corneal Neovascularization 01/2021
1	COVID-19 01/2021
1	Severe Acute Respiratory Syndrome 01/2021
1	Choroid Diseases 01/2021
1	Fundus Albipunctatus 01/2020
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020
1	Compartment Syndromes 06/2019
1	Macular Edema 06/2019
1	Retinal Perforations 06/2019
1	Proliferative Vitreoretinopathy 04/2019
1	Keratoconus 04/2019
1	Bullous Pemphigoid (Pemphigoid) 03/2019
1	Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa) 03/2019
1	Autoimmune Diseases (Autoimmune Disease) 03/2019
1	Glaucoma 01/2019
1	Cataract (Cataracts) 01/2019
1	Retinal Dystrophies 01/2019
1	Corneal Diseases (Corneal Disease) 01/2019
1	Scotoma (Scintillating Scotoma) 01/2017
1	Albinism 01/2016
1	Rare Diseases (Rare Disease) 11/2014
1	Choroidal Neovascularization 10/2011

Drug/Important Bio-Agent (IBA)

37	Retinaldehyde (Retinal)IBA 08/2022 - 04/2002
5	Biomarkers (Surrogate Marker)IBA 04/2020 - 09/2010
5	Macular PigmentIBA 01/2016 - 06/2008
4	Complement System Proteins (Complement)IBA 01/2022 - 07/2008
4	Retinal Pigments (Pigments, Visual)IBA 09/2021 - 05/2013
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 04/2007
4	Bevacizumab (Avastin)FDA Link 01/2008 - 01/2007
3	TESIBA 01/2022 - 01/2020
3	Complement Factor H (Factor H)IBA 04/2012 - 10/2009
3	Ranibizumab (Lucentis)FDA Link 10/2011 - 09/2010
3	Fluorescein (Funduscein)FDA LinkGeneric 12/2009 - 11/2005
2	LipofuscinIBA 01/2022 - 01/2009
2	RNA (Ribonucleic Acid)IBA 01/2021 - 06/2019
2	RetinoidsIBA 01/2017 - 12/2003
2	Complement C3 (C3 Complement)IBA 04/2012 - 10/2009
2	Protein Isoforms (Isoforms)IBA 12/2010 - 04/2007
1	Oxygen (Dioxygen)IBA 08/2022
1	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 01/2022
1	Vitamin A (Retinol)FDA LinkGeneric 01/2022
1	5' Untranslated Regions (5' UTR)IBA 01/2022
1	LipocalinsIBA 01/2021
1	prostaglandin R2 D-isomerase (prostaglandin D2 synthase)IBA 01/2021
1	ParaffinIBA 01/2021
1	Neuroprotective AgentsIBA 01/2021
1	Formaldehyde (Formol)FDA Link 01/2021
1	Carrier Proteins (Binding Protein)IBA 01/2020
1	GoldIBA 01/2020
1	2,4- diamino- 5- cyclohexyl- 6- methylpyrimidineIBA 06/2019
1	Silicone OilsIBA 04/2019
1	Immunoglobulin A (IgA)IBA 03/2019
1	KalininIBA 03/2019
1	Matrix Metalloproteinases (MMPs)IBA 03/2019
1	hydroxide ionIBA 01/2017
1	Adenosine Triphosphate (ATP)IBA 01/2017
1	Melanins (Melanin)IBA 01/2016
1	lecithin-retinol acyltransferaseIBA 01/2015
1	retinol acetateIBA 01/2015
1	Glycoproteins (Glycoprotein)IBA 11/2014
1	ElastinIBA 11/2014
1	Fibrillin-2IBA 11/2014
1	LuteinIBA 05/2013
1	ZeaxanthinsIBA 05/2013
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 04/2012
1	Complement Inactivating AgentsIBA 10/2011

Therapy/Procedure

6	Lasers (Laser) 01/2022 - 07/2007
6	Vitrectomy 06/2021 - 01/2019
4	Therapeutics 01/2021 - 09/2010
3	Corneal Transplantation (Keratoplasty) 01/2022 - 04/2019
2	Plasmapheresis 12/2010 - 05/2009
1	Transplantation 09/2021
1	Cell Transplantation 01/2021
1	Corneal Cross-Linking 04/2019
1	Refractive Surgical Procedures 01/2019